E
Eugene Braunwald
Researcher at Brigham and Women's Hospital
Publications - 1758
Citations - 278949
Eugene Braunwald is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 230, co-authored 1711 publications receiving 264576 citations. Previous affiliations of Eugene Braunwald include Boston University & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Edoxaban versus warfarin in 841 patients with atrial fibrillation and peripheral arterial disease: insights from the engage af-timi 48 trial
Jonathan W. Cunningham,Robert P. Giugliano,Eugene Braunwald,Marco Trevisan,Francesco Nordio,Ton Oude Ophuis,Mijo Bergovec,Michele Mercuri,Christian T. Ruff,Marc P. Bonaca +9 more
TL;DR: The balance of efficacy and safety of various antithrombotics in pts with atrial fibrillation and PAD is unclear and edoxaban and warfarin were compared.
Journal ArticleDOI
TCT-78 Efficacy of Long-Term Ticagrelor in Stented Patients in PEGASUS-TIMI 54
Marc P. Bonaca,Deepak L. Bhatt,Philippe Gabriel Steg,Andrej Budaj,Sameer Bansilal,Robert F. Storey,KyungAh Im,Giulia Magnani,T. Oude Ophuis,Michael Ruda,Christian W. Hamm,Jindrich Spinar,Róbert Gábor Kiss,Rafael Diaz,Frans Van de Werf,Gilles Montalescot,Eva C. Jensen,Peter Held,Eugene Braunwald,Marc S. Sabatine +19 more
TL;DR: Ticagrelor in patients with prior MI reduced the incidence of CV death, MI, or stroke by 15-16% in PEGASUS-TIMI 54 and the efficacy was investigated based on the presence and type of stent.
Journal ArticleDOI
Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy.
C. Michael Gibson,Yuri B. Pride,Jacqueline L. Buros,Vijayalakshmi Kunadian,Matthew C. Southard,Caitlin J. Harrigan,Lauren N. Ciaglo,Marc S. Sabatine,Christopher P. Cannon,Eugene Braunwald +9 more
TL;DR: In patients who undergo PCI after fibrinolytic therapy for STEMI, hyperemic flow on coronary angiography is associated with an increased incidence of adverse outcomes, which may be a marker of more extensive downstream microembolization.
Journal ArticleDOI
Idiopathic hypertrophic subaortic stenosis.
TL;DR: Although the course was extremely variable, the patients who were asymptomatic initially tended to remain so, while those who were more disabled generally deteriorated, died, or improved spontaneously, according to the natural history of IHSS.